» Articles » PMID: 25002516

Astrocyte Activation is Suppressed in Both Normal and Injured Brain by FGF Signaling

Overview
Specialty Science
Date 2014 Jul 9
PMID 25002516
Citations 80
Authors
Affiliations
Soon will be listed here.
Abstract

In the brain, astrocytes are multifunctional cells that react to insults and contain damage. However, excessive or sustained reactive astrocytes can be deleterious to functional recovery or contribute to chronic inflammation and neuronal dysfunction. Therefore, astrocyte activation in response to damage is likely to be tightly regulated. Although factors that activate astrocytes have been identified, whether factors also exist that maintain astrocytes as nonreactive or reestablish their nonreactive state after containing damage remains unclear. By using loss- and gain-of-function genetic approaches, we show that, in the unperturbed adult neocortex, FGF signaling is required in astrocytes to maintain their nonreactive state. Similarly, after injury, FGF signaling delays the response of astrocytes and accelerates their deactivation. In addition, disrupting astrocytic FGF receptors results in reduced scar size without affecting neuronal survival. Overall, this study reveals that the activation of astrocytes in the normal and injured neocortex is not only regulated by proinflammatory factors, but also by factors such as FGFs that suppress activation, providing alternative therapeutic targets.

Citing Articles

FGF21, a modulator of astrocyte reactivity, protects against ischemic brain injury through anti-inflammatory and neurotrophic pathways.

Wang D, Huang W, Shi J, Liu F, Jiang W, Chen K Acta Pharmacol Sin. 2025; .

PMID: 40021824 DOI: 10.1038/s41401-024-01462-x.


Study on the Polarization of Astrocytes in the Optic Nerve Head of Rats Under High Intraocular Pressure: In Vitro.

Ma B, Ren J, Qian X Bioengineering (Basel). 2025; 12(2).

PMID: 40001624 PMC: 11852053. DOI: 10.3390/bioengineering12020104.


From Physiology to Pathology of Astrocytes: Highlighting Their Potential as Therapeutic Targets for CNS Injury.

Yuan Y, Liu H, Dai Z, He C, Qin S, Su Z Neurosci Bull. 2024; 41(1):131-154.

PMID: 39080102 PMC: 11748647. DOI: 10.1007/s12264-024-01258-3.


Engineering human midbrain organoid microphysiological systems to model prenatal PFOS exposure.

Tian C, Cai H, Ao Z, Gu L, Li X, Niu V Sci Total Environ. 2024; 947:174478.

PMID: 38964381 PMC: 11404128. DOI: 10.1016/j.scitotenv.2024.174478.


DHM/SERS reveals cellular morphology and molecular changes during iPSCs-derived activation of astrocytes.

Bu X, Yang L, Han X, Liu S, Lu X, Wan J Biomed Opt Express. 2024; 15(6):4010-4023.

PMID: 38867782 PMC: 11166415. DOI: 10.1364/BOE.524356.


References
1.
Goetz R, Mohammadi M . Exploring mechanisms of FGF signalling through the lens of structural biology. Nat Rev Mol Cell Biol. 2013; 14(3):166-80. PMC: 3695728. DOI: 10.1038/nrm3528. View

2.
Reilly J, Maher P, Kumari V . Regulation of astrocyte GFAP expression by TGF-beta1 and FGF-2. Glia. 1998; 22(2):202-10. DOI: 10.1002/(sici)1098-1136(199802)22:2<202::aid-glia11>3.0.co;2-1. View

3.
Bush T, Puvanachandra N, Horner C, Polito A, Ostenfeld T, Svendsen C . Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron. 1999; 23(2):297-308. DOI: 10.1016/s0896-6273(00)80781-3. View

4.
Sousa V, Miyoshi G, Hjerling-Leffler J, Karayannis T, Fishell G . Characterization of Nkx6-2-derived neocortical interneuron lineages. Cereb Cortex. 2009; 19 Suppl 1:i1-10. PMC: 2693535. DOI: 10.1093/cercor/bhp038. View

5.
Robel S, Mori T, Zoubaa S, Schlegel J, Sirko S, Faissner A . Conditional deletion of beta1-integrin in astroglia causes partial reactive gliosis. Glia. 2009; 57(15):1630-47. DOI: 10.1002/glia.20876. View